Remed Co.,Ltd. (KOSDAQ:302550)

South Korea · Delayed Price · Currency is KRW

2,705.00

-40.00 (-1.46%)

At close: Jul 10, 2026

-23.70% (1Y)

Market Cap	83.60B -29.6%
Revenue (ttm)	25.24B -5.4%
Net Income	1.19B -84.6%
EPS	30.31 -87.4%
Shares Out	30.91M
PE Ratio	89.25
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,844
Open	2,660.00
Previous Close	2,745.00
Day's Range	2,660.00 - 2,755.00
52-Week Range	2,300.00 - 4,595.00
Beta	0.64
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About Remed

Remed Co.,Ltd. engages in the manufacture and supply of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as stroke, autism, dementia, Parkinson's disease, developmental disorders, and tinnitus. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells, and contraction and relaxation of muscles, as well as core muscle strengthening magnetic stimulation to enable building toned and shaped muscles. In a... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus

Founded 2003

Employees 87

Stock Exchange KOSDAQ

Ticker Symbol 302550

Full Company Profile

Financial Performance

In 2025, Remed's revenue was 24.50 billion, a decrease of -4.11% compared to the previous year's 25.55 billion. Earnings were 526.20 million, a decrease of -92.66%.

Financial Statements